2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 418.386 | 426.007 | 424.138 | 426.548 | 566.162 | 616.807 | 673.681 | 715.431 | 790.257 | 848.094 |
Total Income - EUR | 421.232 | 443.023 | 424.446 | 426.798 | 566.643 | 617.898 | 674.397 | 715.801 | 792.024 | 850.605 |
Total Expenses - EUR | 365.961 | 382.831 | 366.213 | 372.118 | 497.832 | 544.569 | 609.069 | 635.315 | 700.625 | 760.839 |
Gross Profit/Loss - EUR | 55.271 | 60.193 | 58.233 | 54.680 | 68.811 | 73.329 | 65.328 | 80.486 | 91.399 | 89.765 |
Net Profit/Loss - EUR | 45.788 | 49.816 | 48.282 | 49.852 | 63.064 | 67.615 | 59.888 | 73.727 | 83.485 | 78.454 |
Employees | 3 | 3 | 3 | 3 | 4 | 5 | 5 | 5 | 5 | 5 |
Check the financial reports for the company - Darifarm Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 171.222 | 147.079 | 172.970 | 160.337 | 150.540 | 137.331 | 126.095 | 115.111 | 118.465 | 112.362 |
Current Assets | 119.140 | 140.917 | 110.625 | 118.575 | 154.661 | 141.058 | 167.955 | 210.093 | 215.504 | 266.710 |
Inventories | 90.080 | 111.180 | 96.807 | 94.050 | 103.726 | 112.141 | 120.786 | 162.747 | 152.617 | 191.088 |
Receivables | 27.233 | 25.438 | 5.846 | 19.123 | 38.659 | 26.619 | 39.625 | 43.007 | 53.145 | 56.942 |
Cash | 1.827 | 4.299 | 7.972 | 5.402 | 12.275 | 2.299 | 7.544 | 4.340 | 9.742 | 18.680 |
Shareholders Funds | 164.505 | 169.524 | 166.769 | 166.335 | 177.409 | 179.745 | 169.892 | 181.292 | 84.631 | 79.597 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 125.857 | 118.915 | 116.826 | 112.578 | 127.793 | 98.644 | 124.157 | 143.912 | 249.337 | 299.536 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Darifarm Srl